This Experimental Treatment Cut Cholesterol by 62 Percent—With No Statins

A groundbreaking study in the New England Journal of Medicine shows a new experimental treatment can slash "bad" cholesterol by 62 percent with just one dose, potentially offering a game-changer for those wary of long-term statin use. This treatment's success could revolutionize how we manage cholesterol levels, providing an alternative that avoids the side effects and dependency often associated with statins. The implications are huge, especially for individuals who struggle with the side effects of traditional medications or prefer non-pharmaceutical solutions.